As active pharmaceutical ingredients (APIs) and medicines become more complex and the demand for efficiency rises, drug ...
From exploring the wonders of plants as a curious teen to leading global initiatives at SCIEX, Gitte Barknowitz has carved ...
Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...
The big pharma company AstraZeneca has forged a licensing pact worth $2 billion with the Chinese firm CSPC Pharmaceutical Group for access to an experimental small molecule treatment for dyslipidemia.
At the forefront of precision dosing, Sharmeen leads DoseMe's efforts to transform personalized medicine from lab research to bedside application. With a background in pharmacy and specialized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback